Hoth Therapeutics (HOTH) Competitors $1.38 +0.04 (+2.61%) As of 01:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOTH vs. ANRO, CLSD, ASRT, MGX, BMEA, VHAQ, IZTC, PMVP, RPTX, and MNOVShould you be buying Hoth Therapeutics stock or one of its competitors? The main competitors of Hoth Therapeutics include Alto Neuroscience (ANRO), Clearside Biomedical (CLSD), Assertio (ASRT), Metagenomi (MGX), Biomea Fusion (BMEA), Viveon Health Acquisition (VHAQ), Invizyne Technologies (IZTC), PMV Pharmaceuticals (PMVP), Repare Therapeutics (RPTX), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry. Hoth Therapeutics vs. Its Competitors Alto Neuroscience Clearside Biomedical Assertio Metagenomi Biomea Fusion Viveon Health Acquisition Invizyne Technologies PMV Pharmaceuticals Repare Therapeutics MediciNova Hoth Therapeutics (NASDAQ:HOTH) and Alto Neuroscience (NYSE:ANRO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations. Does the media prefer HOTH or ANRO? In the previous week, Hoth Therapeutics had 1 more articles in the media than Alto Neuroscience. MarketBeat recorded 1 mentions for Hoth Therapeutics and 0 mentions for Alto Neuroscience. Hoth Therapeutics' average media sentiment score of 1.87 beat Alto Neuroscience's score of 0.00 indicating that Hoth Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Hoth Therapeutics Very Positive Alto Neuroscience Neutral Which has higher valuation and earnings, HOTH or ANRO? Hoth Therapeutics is trading at a lower price-to-earnings ratio than Alto Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHoth TherapeuticsN/AN/A-$8.19M-$1.14-1.21Alto NeuroscienceN/AN/A-$61.43M-$2.34-1.12 Which has more volatility and risk, HOTH or ANRO? Hoth Therapeutics has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, Alto Neuroscience has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Do insiders & institutionals believe in HOTH or ANRO? 7.1% of Hoth Therapeutics shares are owned by institutional investors. 6.9% of Hoth Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is HOTH or ANRO more profitable? Alto Neuroscience's return on equity of -39.35% beat Hoth Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Hoth TherapeuticsN/A -109.18% -100.22% Alto Neuroscience N/A -39.35%-33.86% Do analysts rate HOTH or ANRO? Hoth Therapeutics presently has a consensus price target of $4.00, indicating a potential upside of 190.91%. Alto Neuroscience has a consensus price target of $8.50, indicating a potential upside of 224.43%. Given Alto Neuroscience's higher possible upside, analysts plainly believe Alto Neuroscience is more favorable than Hoth Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hoth Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Alto Neuroscience 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 SummaryHoth Therapeutics beats Alto Neuroscience on 8 of the 14 factors compared between the two stocks. Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOTH vs. The Competition Export to ExcelMetricHoth TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.16M$2.92B$5.56B$9.30BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-1.2120.3528.6119.64Price / SalesN/A304.32437.49188.30Price / CashN/A43.1536.0257.93Price / Book1.607.718.185.63Net Income-$8.19M-$55.11M$3.23B$257.73M7 Day Performance-3.85%0.68%-0.25%0.07%1 Month Performance4.96%8.22%5.40%8.32%1 Year Performance47.85%-2.64%26.35%13.78% Hoth Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOTHHoth Therapeutics3.273 of 5 stars$1.38+2.6%$4.00+190.9%+52.3%$18.16MN/A-1.214Positive NewsANROAlto Neuroscience2.1394 of 5 stars$2.30-2.1%$8.50+269.6%-82.2%$63.62MN/A-0.98N/ACLSDClearside Biomedical2.0639 of 5 stars$0.82+0.3%$4.75+482.8%-33.3%$63.12M$1.66M-1.9930Positive NewsASRTAssertio1.8472 of 5 stars$0.66+0.5%$2.75+319.0%-57.1%$62.54M$124.96M-2.0520News CoverageMGXMetagenomi2.8876 of 5 stars$1.69+1.2%$13.00+669.2%-57.8%$62.43M$52.29M-0.80236Gap UpBMEABiomea Fusion3.6244 of 5 stars$1.69+1.8%$21.40+1,166.3%-66.8%$62.37MN/A-0.4850Positive NewsAnalyst ForecastGap UpVHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumeIZTCInvizyne TechnologiesN/A$9.91-2.8%N/AN/A$61.96MN/A0.0029Gap DownPMVPPMV Pharmaceuticals3.1522 of 5 stars$1.20+0.8%$5.50+358.3%-18.4%$61.82MN/A-1.0250Positive NewsRPTXRepare Therapeutics2.9083 of 5 stars$1.42-1.4%$4.50+216.9%-60.3%$61.76M$53.48M-0.47180News CoveragePositive NewsGap UpMNOVMediciNova1.6233 of 5 stars$1.25flat$7.00+460.0%-13.4%$61.31M$1M-5.4310 Related Companies and Tools Related Companies Alto Neuroscience Alternatives Clearside Biomedical Alternatives Assertio Alternatives Metagenomi Alternatives Biomea Fusion Alternatives Viveon Health Acquisition Alternatives Invizyne Technologies Alternatives PMV Pharmaceuticals Alternatives Repare Therapeutics Alternatives MediciNova Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOTH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOTH Stock Alerts